Follow-on roundup: Alnylam, GlycoMimetics, Albireo

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), GlycoMimetics Inc. (NASDAQ:GLYC) and Albireo Pharma Inc. (NASDAQ:ALBO) all priced follow-ons Wednesday, raising a combined $485 million.

Alnylam raised $359.4 million via the sale of 5 million shares at $71.87 in an offering underwritten by Barclays Capital. The price is a 4% discount to Alnylam’s close of $74.87 on Tuesday, before the company proposed the offering after market hours. Alnylam lost $4.90 to $69.97 on Wednesday...